Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-18

Clinical Trial Update: Effect of Oral Administration of a Herbarium Mixture (Guazuma Ulmifolia and Tecoma Stans) on Metabolic Profile in Type 2 Diabetic Patients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the completion of Phase 2/Phase 3 evaluating an oral herbarium mixture of Guazuma ulmifolia and Tecoma stans and its effec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Herbarium mixture of Guazuma ulmifolia and Tecoma stans

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED